CardioPharma Requests Applications to Investigate the Non-Cardiovascular Benefits of CVD Polypills
CardioPharma, Inc. (the “Company”), a specialty pharmaceutical company focused on combinatorial drug development for cardiovascular diseases, is seeking applications for secondary analyses of existing datasets to investigate thenon-cardiovascular (non-CVD) benefits of the CVD polypill (3 or more medications). While the polypill (fixed-dose combination therapy) is primarily intended for CVD prevention and treatment, emerging evidence suggests […]